Declining incidence of ventricular fibrillation in myocardial infarction. Implications for the prophylactic use of lidocaine.
Author(s) -
Elliott M. Antman,
Jesse A. Berlin
Publication year - 1992
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/01.cir.86.3.764
Subject(s) - medicine , lidocaine , myocardial infarction , randomized controlled trial , ventricular fibrillation , anesthesia , cardiology , cardiogenic shock , incidence (geometry) , physics , optics
The purposes of the present investigation were 1) to track the incidence of primary ventricular fibrillation (VF) in the control and lidocaine-treated groups in the randomized control trials (RCTs) of lidocaine prophylaxis against primary VF in acute myocardial infarction, with particular emphasis on the time frame of the randomized trial, and 2) to estimate the number of patients who must receive lidocaine currently to prevent one episode of VF.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom